Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Effect of Cannabidiol Oil on Post-ureteroscopy Pain for Urinary Calculi: A Randomized, Double-blind, Placebo-controlled Trial
Narang, Gopal , Moore, Jonathan , Wymer, Kevin , Lim, Elisabeth S. , Humphreys, Mitchell R. , Stern, Karen , Lim, Elisabeth, Adeleye, Olufunmilola , Stern, Karen L , Chang, Yu‐Hui

Mayo Clinic

Journal of Urology | March 9, 2023 | Volume: 209 | Issue: 4 | Pages: 726-733

10.1097/ju.0000000000003139 | PMID 36891837 Get It

Endoscopic Urethral Stump Closure with a Novel Suture Device
Kemble, Jayson , Balzano, Felicia, Warner, Jonathan N. , Kemble, Jayson P , Findlay, Bridget L.

Mayo Clinic

Videourology™ | March 8, 2023 | Volume: 37 | Issue: 1 | Pages: No page available

10.1089/vid.2022.0067 Get It

Clinical History: A 60-year-old man with a history of muscle invasive small cell carcinoma of the bladder underwent robot-assisted radical cystectomy with pelvic lymph node dissection and Indiana pouch creation. He underwent aspiration and endoscopic urethral fulguration for a symptomatic lymphocele without improvement. Physical Examination: Clear fluid draining per urethra. CT of abdomen/pelvis showed unchanged loculated fluid collections within the dependent pelvis 2 months after aspiration and urethral fulguration. Diagnosis: Pelvic lymphocele with drainage per urethra. Intervention: Fulguration and closure of the urethral stump using a laparoscopic suture device (RD-180; LSI Solutions, Rochester, NY) and novel endoscopic sheath (JNW Urtract TM ; LSI Solutions). Before surgery, a pigtail drain was placed in the pelvic fluid collection. The proximal stump was fulgurated using the bipolar plasma band through a 27F cystourethroscope (Olympus Surgical Technologies America, Westborough, MA) to facilitate scarring. The stump was closed using the RD-180 under direct observation in a figure of eight manner both proximally at the opening and 1 cm distally. Knots were fashioned using the Ti-Knot fastener (LSI Solutions). Total operative time 37 minutes. Follow-Up/Outcomes: Patient was dismissed same-day following surgery. CT scan 2 months postoperatively demonstrated resolution of pelvic fluid collection, and his drain was removed. He remains asymptomatic without recurrence or urethral drainage 4 months postoperatively. To our knowledge, this is the first described case of endoscopic closure of a urethral stump in the setting of persistent drainage from a pelvic lymphocele. Fulguration with endoscopic closure using a novel device is both a safe and efficacious alternative to performing urethral fulguration alone. No competing financial interests exist. No funding was received for this article. Patient consent statement: Patient consented to the use of nonidentifiable intraoperative photography and video recording for the purpose of medical education and publication in professional journals. Authors have received and archived patient consent for video recording/publication in advance of video recording of procedure. Music: All music was from Pixabay.com, royalty free. Runtime of video: 4 mins 4 secs
Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer’s disease
Corriveau‐Lecavalier, Nick , Gunter, Jeffrey L. , Kamykowski, Michael G. , Dicks, Ellen , Botha, Hugo , Kremers, Walter K. , Graff‐Radford, Jonathan , Wiepert, Daniela A. , Schwarz, Christopher G. , Yacoub, Essa , Knopman, David S. , Boeve, Bradley F. , Uǧurbil, Kǎmil , Petersen, Ronald C. , Jack, Clifford R. , Terpstra, Melissa , Jones, David T. , Knopman, David S. , Kamykowski, Michael, Jack, Clifford R , Schwarz, Christopher G , Boeve, Brad , Botha, Hugo , Jones, David T , Corriveau-Lecavalier, Nick , Kremers, Walter K

Mayo Clinic

Brain Communications | March 8, 2023 | Volume: 5 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcad058 | PMID 37013176 Get It

AbstractFrom a complex systems perspective, clinical syndromes emerging from neurodegenerative diseases are thought to result from multiscale interactions between aggregates of misfolded proteins and the disequilibrium of large-scale networks coordinating functional operations underpinning cognitive phenomena. Across all syndromic presentations of Alzheimer’s disease, age-related disruption of the default mode network is accelerated by amyloid deposition. Conversely, syndromic variability may reflect selective neurodegeneration of modular networks supporting specific cognitive abilities. In this study, we leveraged the breadth of the Human Connectome Project-Aging cohort of non-demented individuals (N = 724) as a normative cohort to assess the robustness of a biomarker of default mode network dysfunction in Alzheimer’s disease, the network failure quotient, across the aging spectrum. We then examined the capacity of the network failure quotient and focal markers of neurodegeneration to discriminate patients with amnestic (N = 8) or dysexecutive (N = 10) Alzheimer’s disease from the normative cohort at the patient level, as well as between Alzheimer’s disease phenotypes. Importantly, all participants and patients were scanned using the Human Connectome Project-Aging protocol, allowing for the acquisition of high-resolution structural imaging and longer resting-state connectivity acquisition time. Using a regression framework, we found that the network failure quotient related to age, global and focal cortical thickness, hippocampal volume, and cognition in the normative Human Connectome Project-Aging cohort, replicating previous results from the Mayo Clinic Study of Aging that used a different scanning protocol. Then, we used quantile curves and group-wise comparisons to show that the network failure quotient commonly distinguished both dysexecutive and amnestic Alzheimer’s disease patients from the normative cohort. In contrast, focal neurodegeneration markers were more phenotype-specific, where the neurodegeneration of parieto-frontal areas associated with dysexecutive Alzheimer’s disease, while the neurodegeneration of hippocampal and temporal areas associated with amnestic Alzheimer’s disease. Capitalizing on a large normative cohort and optimized imaging acquisition protocols, we highlight a biomarker of default mode network failure reflecting shared system-level pathophysiological mechanisms across aging and dysexecutive and amnestic Alzheimer’s disease and biomarkers of focal neurodegeneration reflecting distinct pathognomonic processes across the amnestic and dysexecutive Alzheimer’s disease phenotypes. These findings provide evidence that variability in inter-individual cognitive impairment in Alzheimer’s disease may relate to both modular network degeneration and default mode network disruption. These results provide important information to advance complex systems approaches to cognitive aging and degeneration, expand the armamentarium of biomarkers available to aid diagnosis, monitor progression and inform clinical trials.
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design
Petersen, Ivy A. , Imai, Reiko , Hug, Eugen B., Fiore, Maria Rosaria , Fossati, Piero , Yamada, Shigeru , Orlandi, Ester , Zhang, Qing, Bao, Cihang , Seidensaal, Katharina , May, Byron C. , Harrell, Anna , Houdek, Matthew T. , Vallow, Laura A., Rose, Peter S. , Haddock, Michael G. , Ashman, Jonathan B. , Goulding, Krista , Attia, Steven , Krishnan, Sunil , Mahajan, Anita , Foote, Robert L. , Keole, Sameer R., Beltran, Chris , Welch, Eric M., Wilke, Benjamin K. , Imai, Reiko , Yamada, Shigeru , Zhang, Qing , May, Byron C , Harrell, Anna C , Houdek, Matthew T , Goulding, Krista A., Krishnan, Sunil , Foote, Robert , Karim, Mohammed, Ahmed, Safia K. , Beltran, Chris J , Hoppe, Bradford S. , DeWees, T.A. , Debus, Jürgen , Laack, Nadia N. , Karim, Mohammed

Mayo Clinic

Cancers | March 8, 2023 | Volume: 15 | Issue: 6 | Pages: 1660

10.3390/cancers15061660 | PMID 36980545 Get It

Surgical treatment of pelvic sarcoma involving the bone is the standard of care but is associated with several sequelae and reduced functional quality of life (QOL). Treatment with photon and proton radiotherapy is associated with relapse. Carbon ion radiotherapy (CIRT) may reduce both relapse rates and treatment sequelae. The PROSPER study is a tricontinental, nonrandomized, prospective, three-arm, pragmatic trial evaluating treatments of pelvic sarcoma involving the bone. Patients aged at least 15 years are eligible for inclusion. Participants must have an Eastern Cooperative Oncology Group Performance Status score of two or less, newly diagnosed disease, and histopathologic confirmation of pelvic chordoma, chondrosarcoma, osteosarcoma, Ewing sarcoma with bone involvement, rhabdomyosarcoma (RMS) with bone involvement, or non-RMS soft tissue sarcoma with bone involvement. Treatment arms include (1) CIRT (n = 30) delivered in Europe and Asia, (2) surgical treatment with or without adjuvant radiotherapy (n = 30), and (3) proton therapy (n = 30). Arms two and three will be conducted at Mayo Clinic campuses in Arizona, Florida, and Minnesota. The primary end point is to compare the 1-year change in functional QOL between CIRT and surgical treatment. Additional comparisons among the three arms will be made between treatment sequelae, local control, and other QOL measures.
The effects of COVID‐19 on pediatric and adult solid organ transplant recipients and the emergence of telehealth
Shah, Raghav , Marks, Stephen D. , Johnson, Jonathan N. , Nied, Matthew, Bhatt, Girish Chandra , Bonham, Clark A. , Datla, Nithin, Sethi, Sidharth Kumar , Shah, Raghav , Johnson, Jonathan , Sethi, Sidharth Kumar , Raina, Rupesh , Bartosh, Sharon

Mayo Clinic

Pediatric Transplantation | March 7, 2023 | Volume: 27 | Issue: 4 | Pages: No page available

10.1111/petr.14490 | PMID 36879358 Get It

AbstractBackgroundThe SARS‐CoV‐2 pandemic and corresponding acute respiratory syndrome have affected all populations and led to millions of deaths worldwide. The pandemic disproportionately affected immunocompromised and immunosuppressed adult patients who had received solid organ transplants (SOTs). With the onset of the pandemic, transplant societies across the world recommended reducing SOT activities to avoid exposing immunosuppressed recipients. Due to the risk of COVID‐19‐related outcomes, SOT providers adapted the way they deliver care to their patients, leading to a reliance on telehealth. Telehealth has helped organ transplant programs continue treatment regimens while protecting patients and physicians from COVID‐19 transmission. This review highlights the adverse effects of COVID‐19 on transplant activities and summarizes the increased role of telehealth in the management of solid organ transplant recipients (SOTRs) in both pediatric and adult populations.MethodsA comprehensive systematic review and meta‐analysis were conducted to accentuate the outcomes of COVID‐19 and analyze the efficacy of telehealth on transplant activities. This in‐depth examination summarizes extensive data on the clinical detriments of COVID‐19 in transplant recipients, advantages, disadvantages, patient/physician perspectives, and effectiveness in transplant treatment plans via telehealth.ResultsCOVID‐19 has caused an increase in mortality, morbidity, hospitalization, and ICU admission in SOTRs. Telehealth efficacy and benefits to both patients and physicians have increasingly been reported.ConclusionsDeveloping effective systems of telehealth delivery has become a top priority for healthcare providers during the COVID‐19 pandemic. Further research is necessary to validate the effectiveness of telehealth in other settings.
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, Sarah K. , Damask, Cecelia, Ebert, Charles S. , Levy, Joshua M. , Lin, Sandra Y. , Luong, Amber , Rodriguez, Kenneth , Sedaghat, Ahmad R. , Toskala, Elina , Akdiş, Cezmi A. , Ansotegui, Ignacio J. , Azar, Antoine , Baroody, Fuad M. , Benninger, Michael S. , Casale, Thomas B. , Chaaban, Mohamad R. , Chew, Fook Tim , Chambliss, Jeffrey , Cianferoni, Antonella , Čustović, Adnan , Davis, Elizabeth Mahoney , DelGaudio, John M. , Flanagan, Carrie E. , Franzese, Christine B., Gill, Amarbir S. , Halderman, Ashleigh A. , Joe, Stephanie, Joshi, Shyam , Kuruvilla, Merin , Kim, Jean , Klein, Adam M. , Krouse, Helene J. , Lang, David M. , Laury, Adrienne M., Lee, Victoria S. , Loftus, Patricia A. , Marzouk, Haidy, Mims, James W., Oppenheimer, John , Orlandi, Richard R. , Phillips, Katie M. , Raymond, Mallory , Ryan, Matthew W., Sastre, J. , Schlosser, Rodney J. , Shaker, Marcus , Smith, Kristine A. , Soyka, Michael , Tang, Monica , Tantilipikorn, Pongsakorn , Taw, Malcolm B., Tversky, Jody , Tyler, Matthew A. , Veling, Maria C., Wallace, Dana , White, Andrew A. , Roland, Lauren T , Levy, Joshua M , Luong, Amber U , Sedaghat, Ahmad R , Villwock, Jennifer , Abdullah, Baharudin , Alt, Jeremiah A , Chaaban, Mohamad R , Gill, Amarbir , Kuruvilla, Merin Elizabeth , Kim, Jean , Kuan, Edward C , Lee, Victoria S , Marcus, Sonya , Mattos, Jose , McCoul, Edward D , Nayak, Jayakar V , Orlandi, Richard , Schuman, Theodore A , Smith, Kristine , Soyka, Michael B , Tantilipikorn, Pongsakorn , Tyler, Matthew A , Zhang, Luo , Schlosser, Rodney J , Chew, Fook Tim , Casale, Thomas , Alt, Jeremiah A. , Bernstein, Jonathan A. , Brook, Christopher D. , Campbell, Raewyn Gay , Ellis, Anne K. , Fokkens, Wytske Johanna , Greenhawt, Matthew , Hohlfeld, Jens Michael , Incorvaia, Cristoforo , Larenas‐Linnemann, Désirée E. , Lechner, Matt , Lee, Stella E. , Mattos, José L. , McCoul, Edward D. , Melén, Erik , Mullol, Joaquim , Nayak, Jayakar V. , Platt, Michael P. , Ramanathan, Murugappan , Raymond, Mallory J , Rhee, Chae‐Seo , Reitsma, Sietze , Sheikh, Aziz , Takashima, Masayoshi , Wang, De Yun , Zhang, Luo

Mayo Clinic

International Forum of Allergy & Rhinology | March 6, 2023 | Volume: 13 | Issue: 4 | Pages: 293-859

10.1002/alr.23090 | PMID 36878860 Get It

Abstract Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.
Impact of Genetic Disorders in the Surgical Management of Congenital Heart Disease
Stephens, Elizabeth H. , Dearani, Joseph A. , Connolly, Heidi M. , Gleich, Stephen J. , Deyle, David R. , Johnson, Jonathan N. , Dearani, Joseph A.

Mayo Clinic

World Journal for Pediatric and Congenital Heart Surgery | March 3, 2023 | Volume: 14 | Issue: 2 | Pages: 201-210

10.1177/21501351221139837 | PMID 36866650 Get It

The congenital heart surgeon frequently encounters patients with various genetic disorders requiring surgical intervention. Although the specifics of the genetics for these patients and their families lie in the purview of specialists in genetics, the surgeon is well-served to be familiar with aspects of specific syndromes that impact surgical management and perioperative care. This aids in counseling families in expectations for the hospital course and recovery as well as can impact intraoperative and surgical management. This review article summarizes key characteristics for the congenital heart surgeon to be familiar with for common genetic disorders as they help coordinate care.
The radiologically isolated syndrome: revised diagnostic criteria
Lebrun‐Frénay, Christine , Okuda, Darin T. , Sıva, Aksel , Landes-Château, Cassandre , Azevedo, Christina , Mondot, Lydiane , Louapre, Céline , Durand‐Dubief, Françoise , Page, Emmanuelle Le , Bensa, Caroline , Ciron, Jonathan , Casez, Olivier , Mathey, Guillaume , Zeydan, Burcu , Makhani, Naila , Tütüncü, Melih , Levraut, Michaël , Thouvenot, Éric , Pelletier, Daniel , Kantarci, Orhun H. , Zeydan, Burcu , Lebrun‐Frénay, Christine , Siva, Aksel , Thouvenot, Eric , Ciron, Jonathan , Durand-Dubief, Françoise , Okuda, Darin T , Mondot, Lydiane , Carra‐Dallière, Clarisse , Zéphir, Hélène , Bensa, Caroline , Ruet, Aurélie , Laplaud, David , Casez, Olivier , Seze, Jerome De , Cohen, Mikaël

Mayo Clinic

Brain | March 3, 2023 | Volume: 146 | Issue: 8 | Pages: 3431-3443

10.1093/brain/awad073 | PMID 36864688 Get It

Abstract The radiologically isolated syndrome (RIS) was defined in 2009 as the presence of asymptomatic, incidentally identified demyelinating-appearing white matter lesions in the CNS within individuals lacking symptoms typical of multiple sclerosis (MS). The RIS criteria have been validated and predict the transition to symptomatic MS reliably. The performance of RIS criteria that require fewer MRI lesions is unknown. 2009-RIS subjects, by definition, fulfil three to four of four criteria for 2005 dissemination in space (DIS) and subjects fulfilling only one or two lesions in at least one 2017 DIS location were identified within 37 prospective databases. Univariate and multivariate Cox regression models were used to identify predictors of a first clinical event. Performances of different groups were calculated. Seven hundred and forty-seven subjects (72.2% female, mean age 37.7 ± 12.3 years at the index MRI) were included. The mean clinical follow-up time was 46.8 ± 45.4 months. All subjects had focal T2 hyperintensities suggestive of inflammatory demyelination on MRI; 251 (33.6%) fulfilled one or two 2017 DIS criteria (designated as Groups 1 and 2, respectively), and 496 (66.4%) fulfilled three or four 2005 DIS criteria representing 2009-RIS subjects. Group 1 and 2 subjects were younger than the 2009-RIS group and were more likely to develop new T2 lesions over time (P < 0.001). Groups 1 and 2 were similar regarding survival distribution and risk factors for transition to MS. At 5 years, the cumulative probability for a clinical event was 29.0% for Groups 1 and 2 compared to 38.7% for 2009-RIS (P = 0.0241). The presence of spinal cord lesions on the index scan and CSF-restricted oligoclonal bands in Groups 1–2 increased the risk of symptomatic MS evolution at 5 years to 38%, comparable to the risk of development in the 2009-RIS group. The presence of new T2 or gadolinium-enhancing lesions on follow-up scans independently increased the risk of presenting with a clinical event (P < 0.001). The 2009-RIS subjects or Groups 1 and 2 with at least two of the risk factors for a clinical event demonstrated better sensitivity (86.0%), negative predictive value (73.1%), accuracy (59.8%) and area under the curve (60.7%) compared to other criteria studied. This large prospective cohort brings Class I evidence that subjects with fewer lesions than required in the 2009 RIS criteria evolve directly to a first clinical event at a similar rate when additional risk factors are present. Our results provide a rationale for revisions to existing RIS diagnostic criteria.
Characteristics of patients who return to work after undergoing surgery for cervical spondylotic myelopathy: a Quality Outcomes Database study
Michalopoulos, Giorgos D. , Shaffrey, Christopher I. , Gottfried, Oren N., Johnson, Eli , Bisson, Erica F. , Wang, Michael Y. , Knightly, John J. , Virk, Michael S., Tumialán, Luis M. , Turner, Jay D. , Upadhyaya, Cheerag D., Shaffrey, Mark E., Park, Paul , Foley, Kevin T. , Coric, Domagoj , Slotkin, Jonathan R., Potts, Eric A. , Chou, Dean , Fu, Kai-Ming, Haid, Regis W., Asher, Anthony L. , Bydon, Mohamad , Mummaneni, Praveen V. , Than, Khoi D. , Michalopoulos, Giorgos , Bergin, Stephen M., Virk, Michael S.

Mayo Clinic

Journal of Neurosurgery: Spine | March 2, 2023 | Volume: 38 | Issue: 5 | Pages: 530-539

10.3171/2023.1.spine221078 | PMID 36805526 Get It

OBJECTIVE Return to work (RTW) is an important surgical outcome for patients who are employed, yet a significant number of patients with cervical spondylotic myelopathy (CSM) who are employed undergo cervical spine surgery and fail to RTW. In this study, the authors investigated factors associated with failure to RTW in the CSM population who underwent cervical spine surgery and who were considered to have a good surgical outcome yet failed to RTW. METHODS This study retrospectively analyzed prospectively collected data from the cervical myelopathy module of a national spine registry, the Quality Outcomes Database. The CSM data set of the Quality Outcomes Database was queried for patients who were employed at the time of surgery and planned to RTW postoperatively. Distinct multivariable logistic regression models were fitted with 3-month RTW as an outcome for the overall population to identify risk factors for failure to RTW. Good outcomes were defined as patients who had no adverse events (readmissions or complications), who had achieved 30% improvement in Neck Disability Index score, and who were satisfied (North American Spine Society satisfaction score of 1 or 2) at 3 months postsurgery. RESULTS Of the 409 patients who underwent surgery, 80% (n = 327) did RTW at 3 months after surgery. At 3 months, 56.9% of patients met the criteria for a good surgical outcome, and patients with a good outcome were more likely to RTW (88.1% vs 69.2%, p < 0.01). Of patients with a good outcome, 11.9% failed to RTW at 3 months. Risk factors for failing to RTW despite a good outcome included preoperative short-term disability or leave status (OR 3.03 [95% CI 1.66–7.90], p = 0.02); a higher baseline Neck Disability Index score (OR 1.41 [95% CI 1.09–1.84], p < 0.01); and higher neck pain score at 3 months postoperatively (OR 0.81 [95% CI 0.66–0.99], p = 0.04). CONCLUSIONS Most patients with CSM who undergo spine surgery reenter the workforce within 3 months from surgery, with RTW rates being higher among patients who experience good outcomes. Among patients with good outcomes who were employed, failure to RTW was associated with being on preoperative short-term disability or leave status prior to surgery as well as higher neck pain scores at baseline and at 3 months postoperatively.
Contemporary Early Postoperative Cone Repair Outcomes For Patients With Ebstein Anomaly
Phillips, Kari A. , Wackel, Philip L. , Stephens, Elizabeth H. , Weaver, Amy L. , Cetta, Frank , Johnson, Jonathan N. , Dorn, Charlotte S. Van , Dearani, Joseph A. , Krishnan, Prasad

Mayo Clinic

Pediatrics | March 1, 2023 | Volume: 147 | Issue: 3_MeetingAbstract | Pages: 380-381

10.1542/peds.147.3ma4.380b Get It